Fred Saad, MD, FRCSC, is Professor and Chief of Urology and Director of G-U Oncology at the University of Montreal Hospital Centers.
Fred Saad is Professor and Chairman of Urology and Director of Genitourinary Oncology at the University of Montreal Hospital Center (CHUM), in Montreal, QC, Canada. He holds the Raymond Garneau Chair in Prostate Cancer Research and is Director of Clinical Research and the Molecular Oncology Research Laboratory in Prostate Cancer.
Prof. Saad’s research interests include novel therapeutics in prostate cancer, molecular prognostic markers, and mechanisms of progression. He has over 40 clinical and basic research projects ongoing and has received over CAD 40 million in research grants. Prof. Saad currently sits on 15 steering committees of ongoing international clinical trials and serves on several guideline committees.
He is an active member of the Canadian Urological Association (CUA), the American Urological Association (AUA), the American Society of Clinical Oncology (ASCO), the European Society for Medical Oncology (ESMO), and the American Association of Genitourinary Surgeons (AAGUS), and has held several leadership positions including President of the CUA and Chair of the National Cancer Institute of Canada genitourinary group (NCIC G-U) and the Canadian Uro-Oncology Group (CUOG). Prof. Saad is the recipient of numerous awards and honours including Lifetime Achievement Awards from the CHUM Research Center and the Quebec Urological Association (QUA), The Distinguished Contribution Award from the American Urologic Association (AUA) and was named a Knight of The National Order of Quebec, the highest honour given by the Government of Quebec. In 2021 he was named a Fellow of the Canadian Academy of Health Sciences
Prof. Saad has played a leadership role and been co-author of many of the practice-changing clinical trials and publications in advanced prostate cancer over the last 25 years. He is a member of several editorial boards, including Lancet Oncology, JAMA Oncology, Nature Urology and Cancers. Prof. Saad has published over 700 peer-reviewed articles, and with an h-index of 134 and over 90,000 citations he is listed as one of the world’s most-cited clinician-scientists.